Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0AT2Z
|
|||
Former ID |
DNC003596
|
|||
Drug Name |
3-Phenylsulfanylmethyl-quinoxaline-5,7-diamine
|
|||
Synonyms |
CHEMBL141548; 3-Phenylsulfanylmethyl-quinoxaline-5,7-diamine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H14N4S
|
|||
Canonical SMILES |
C1=CC=C(C=C1)SCC2=NC3=C(C=C(C=C3N=C2)N)N
|
|||
InChI |
1S/C15H14N4S/c16-10-6-13(17)15-14(7-10)18-8-11(19-15)9-20-12-4-2-1-3-5-12/h1-8H,9,16-17H2
|
|||
InChIKey |
PBRHNJQCRCVADQ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Polypeptide deformylase (PDF) | Target Info | Inhibitor | [1] |
Pathwhiz Pathway | Folate Metabolism | |||
Pterine Biosynthesis | ||||
Reactome | E2F mediated regulation of DNA replication | |||
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | ||||
Metabolism of folate and pterines | ||||
G1/S-Specific Transcription |
References | Top | |||
---|---|---|---|---|
REF 1 | New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii. J Med Chem. 1995 Nov 24;38(24):4739-59. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.